Causes of death in patients with HIV infection in two Tunisian medical centers
Antiretroviral tritherapy has contributed to a considerable reduction in HIV-related mortality. The causes of death are dominated by opportunistic infections in developing countries and by cardiovascular diseases and cancer in developed countries. To determine the causes and risk factors associated with death in HIV-infected patients in two Tunisian medical centers. cross-sectional study of HIV-infected patients over 15 years treated at Sousse and Monastir medical centers between 2000 and 2014. Death was considered related to HIV if its primary cause was AIDS-defining illness or if it was due to an opportunistic infection of unknown etiology with CD4 < 50 cells/mm3; it was considered unrelated to HIV if its primary cause wasn't an AIDS defining illness or if it was due to an unknown cause if no information was available. Two hundred thirteen patients, 130 men (61%) and 83 women (39%), average age 40 ± 11 years were enrolled in the study. Fifty four patients died, the mortality rate was 5.4/100 patients/year. Annual mortality rate decreased from 5.8% in 2000-2003 to 2.3% in 2012-2014. Survival was 72% at 5 years and 67% at 10 years. Death events were associated with HIV in 70.4% of cases. The leading causes of death were pneumocystis carinii pneumonia and cryptococcal meningitis in 6 cases (11%) each. Mortality risk factors were a personal history of opportunistic infections, duration of antiretroviral therapy < 12 months and smoking. Strengthening screening, early initiation of antiretroviral therapy and fight against tobacco are needed to reduce mortality in patients infected with HIV in Tunisia.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
The Pan African medical journal - 25(2016) vom: 13., Seite 105 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Causes de décès des patients infectés par le VIH dans le Centre tunisien |
|---|
| Beteiligte Personen: |
Chelli, Jihène [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Causes of death |
|---|
| Anmerkungen: |
Date Completed 29.03.2017 Date Revised 13.11.2018 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.11604/pamj.2016.25.105.9748 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM269826505 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM269826505 | ||
| 003 | DE-627 | ||
| 005 | 20231224225317.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.11604/pamj.2016.25.105.9748 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0899.xml |
| 035 | |a (DE-627)NLM269826505 | ||
| 035 | |a (NLM)28292068 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Chelli, Jihène |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Causes of death in patients with HIV infection in two Tunisian medical centers |
| 246 | 3 | 3 | |a Causes de décès des patients infectés par le VIH dans le Centre tunisien |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.03.2017 | ||
| 500 | |a Date Revised 13.11.2018 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Antiretroviral tritherapy has contributed to a considerable reduction in HIV-related mortality. The causes of death are dominated by opportunistic infections in developing countries and by cardiovascular diseases and cancer in developed countries. To determine the causes and risk factors associated with death in HIV-infected patients in two Tunisian medical centers. cross-sectional study of HIV-infected patients over 15 years treated at Sousse and Monastir medical centers between 2000 and 2014. Death was considered related to HIV if its primary cause was AIDS-defining illness or if it was due to an opportunistic infection of unknown etiology with CD4 < 50 cells/mm3; it was considered unrelated to HIV if its primary cause wasn't an AIDS defining illness or if it was due to an unknown cause if no information was available. Two hundred thirteen patients, 130 men (61%) and 83 women (39%), average age 40 ± 11 years were enrolled in the study. Fifty four patients died, the mortality rate was 5.4/100 patients/year. Annual mortality rate decreased from 5.8% in 2000-2003 to 2.3% in 2012-2014. Survival was 72% at 5 years and 67% at 10 years. Death events were associated with HIV in 70.4% of cases. The leading causes of death were pneumocystis carinii pneumonia and cryptococcal meningitis in 6 cases (11%) each. Mortality risk factors were a personal history of opportunistic infections, duration of antiretroviral therapy < 12 months and smoking. Strengthening screening, early initiation of antiretroviral therapy and fight against tobacco are needed to reduce mortality in patients infected with HIV in Tunisia | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Causes of death | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a Tunisia | |
| 650 | 4 | |a opportunistic infections | |
| 650 | 4 | |a risk factors | |
| 700 | 1 | |a Bellazreg, Foued |e verfasserin |4 aut | |
| 700 | 1 | |a Aouem, Abir |e verfasserin |4 aut | |
| 700 | 1 | |a Hattab, Zouhour |e verfasserin |4 aut | |
| 700 | 1 | |a Mesmia, Hèla |e verfasserin |4 aut | |
| 700 | 1 | |a Lasfar, Nadia Ben |e verfasserin |4 aut | |
| 700 | 1 | |a Hachfi, Wissem |e verfasserin |4 aut | |
| 700 | 1 | |a Masmoudi, Tasnim |e verfasserin |4 aut | |
| 700 | 1 | |a Chakroun, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Letaief, Amel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Pan African medical journal |d 2008 |g 25(2016) vom: 13., Seite 105 |w (DE-627)NLM20399910X |x 1937-8688 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2016 |g day:13 |g pages:105 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.11604/pamj.2016.25.105.9748 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2016 |b 13 |h 105 | ||